Organic electroluminescent materials and devices

US10056566B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10056566-B2
Application numberUS-201414225591-A
CountryUS
Kind codeB2
Filing dateMar 26, 2014
Priority dateMar 23, 2009
Publication dateAug 21, 2018
Grant dateAug 21, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel heteroleptic iridium complexes having the structure of Formula I, are provided. In Formula I, X is selected from the group consisting of NR, BR, and Se; R is selected from hydrogen and alkyl, and each R 1 , R 2 , R 3 , and R 4 is independently selected from hydrogen, alkyl, and aryl. The compounds may be used in organic light emitting devices, particularly as emitting dopants, to provide devices having improved efficiency, lifetime, and manufacturing.

First claim

Opening claim text (preview).

The invention claimed is: 1. A heteroleptic compound having the formula: wherein X is NR; wherein R is isobutyl; wherein R 1 , R 2 , R 3 , and R 4 may represent mono, di, tri, or tetra substitutions; and wherein each of R 1 , R 2 , R 3 , and R 4 is independently selected from the group consisting of hydrogen, alkyl, and aryl. 2. The heteroleptic compound of claim 1 , wherein R 1 and R 4 are independently selected from the group consisting of hydrogen and alkyl having four or fewer carbon atoms. 3. The heteroleptic compound of claim 1 , wherein R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl having four or fewer carbon atoms and aryl comprising an aryl ring with 5 or 6 atoms in the aryl ring. 4. The heteroleptic compound of claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of hydrogen, alkyl having four or fewer carbon atoms and aryl comprising an aryl ring with 5 or 6 atoms in the aryl ring. 5. The heteroleptic compound of claim 1 , wherein the compound has the formula: 6. The heteroleptic compound of claim 1 , wherein the compound has the formula: 7. The heteroleptic compound of claim 1 , wherein the compound has the formula: 8. The heteroleptic compound of claim 1 , wherein the compound is 9. The heteroleptic compound of claim 1 , wherein the compound is selected from the group consisting of: 10. A first device comprising an organic light emitting device, comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, the organic layer comprising a heteroleptic compound having the formula: wherein X is NR; wherein R is isobutyl; wherein R 1 , R 2 , R 3 and R 4 may represent mono, di, tri, or tetra substitutions; wherein each of R 1 , R 2 , R 3 and R 4 is independently selected from the group consisting of hydrogen, alkyl, and aryl. 11. The device of claim 10 , wherein the organic layer is an emissive layer and the heteroleptic compound is an emitting dopant. 12. The device of claim 10 , wherein the organic layer further comprises a host. 13. The device of claim 12 , wherein the host comprises a triphenylene moiety and a dibenzothiophene moiety. 14. The device of claim 12 , wherein the host has the formula: wherein R′ 1 , R′ 2 , R′ 4 , and R′ 6 may represent mono, di, tri, or tetra substitutions; wherein R′ 3 and R′ 5 may represent mono, di, or tri substitutions; and wherein each of R′ 1 , R′ 2 , R′ 3 , R′ 4 , R′ 5 , and R′ 6 is independently selected from the group consisting of hydrogen, alkyl, and aryl. 15. A heteroleptic compound having the formula: wherein X is selected from the group consisting of BR and Se; wherein R is selected from hydrogen and alkyl; wherein R 1 , R 2 , R 3 , and R 4 may represent mono, di, tri, or tetra substitutions; and wherein each of R 1 , R 2 , R 3 , and R 4 is independently selected from the group consisting of hydrogen, alkyl, and aryl. 16. The heteroleptic compound of claim 15 , wherein X is Se. 17. The heteroleptic compound of claim 15 , wherein X is BR. 18. The heteroleptic compound of claim 1 wherein the compound is selected from the group consisting of: 19. The heteroleptic compound of claim 1 , wherein the compound is selected from the group consisting of:

Assignees

Inventors

Classifications

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • Non-condensed systems · CPC title

  • Condensed systems · CPC title

  • containing organic luminescent materials · CPC title

  • containing one nitrogen atom as the heteroatom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10056566B2 cover?
Novel heteroleptic iridium complexes having the structure of Formula I, are provided. In Formula I, X is selected from the group consisting of NR, BR, and Se; R is selected from hydrogen and alkyl, and each R 1 , R 2 , R 3 , and R 4 is independently selected from hydrogen, alkyl, and aryl. The compounds may be used in organic light emitting devices, particularly as e…
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).